George Millen: Unscripted

A new platform combines real-time physiological and gas monitoring, promising a proactive shift in safety for workers in the most hazardous industries.

New platform VibeFlow promises to bring AI coding speed to regulated industries by deploying AI agent teams that maintain compliance and auditability.

A new report charts a course for embedding AI into core workflows, aiming to ease clinician burnout and improve care without sacrificing human oversight.

The fintech platform's new fund offers access to consumer loans, but investors must weigh the high-yield promise against underlying market risks.

A new partnership between manufacturing, finance, and compliance experts aims to fast-track U.S. drone production to meet urgent national security demands.

The biotech's blockbuster Nasdaq debut provides crucial capital for its promising pipeline, offering new hope for patients with severe bleeding conditions.

A new survey reveals Canadians are tired of clichés in US TV and want more local content. With new laws in place, is a golden age of CanCon on the horizon?

Omaha's Sequent Planning lands on USA TODAY's prestigious list of top advisors. Discover the blend of strategic growth and fiduciary care that fueled its rise.

With a new corporate-owned store in Nashville, RMCF is testing a new recipe for system-wide growth, blending digital tech with a five-senses experience.

With new FDA clearance, Zeta Surgical's portable AI navigation system could bring millimeter-precision brain surgery to any hospital, not just elite centers.

As JAHM begins, a national effort led by The Weitzman Museum uses education and celebration to counter a documented surge in antisemitism across the U.S.

MidSolid Press & Pour's major expansion addresses critical bottlenecks in the booming waterless cosmetics market, fueling a plastic-free future for beauty.

Detroit announces over 1,600 new hotel rooms and major events like the Final Four, signaling a new era of hospitality and global recognition for the city.

An energy tech firm closes a landmark $25M offering and seeks more to fund its $850M zero-waste facility, betting on a clean future for coal.

Eli Lilly begins a crucial Phase 2 study for a novel, non-addictive pain drug from Confo Therapeutics, a major step in the hunt for an opioid alternative.

A new book argues modern genomics is stuck on a 'parts list.' Can an architectural approach called 'Deterministic Convergence' build a better future for health?

Nanometrology leader Park Systems buys probe maker Rocky Mountain Nanotechnology, a strategic vertical integration securing critical components for future tech.

With fresh capital, the Swedish biotech is scaling its revolutionary platform that decodes cellular communication, fueling a major US expansion.

The Japanese design firm behind the cult-favorite steam toaster is selling a $499 clock. Is it a wellness tool or a luxury gimmick in a connected world?

New data reveals a persistent hunger crisis affecting millions, with advocates blaming policy failure, not scarcity, and demanding urgent federal action.